# In-office Repair of Chronic Tympanic Membrane Perforations

> **NCT06448039** · PHASE1,PHASE2 · SUSPENDED · sponsor: **D. Bradley Welling, MD, PhD** · enrollment: 20 (estimated)

## Conditions studied

- Chronic Tympanic Membrane Perforation

## Interventions

- **DRUG:** Fibroblast Growth Factor 2
- **DRUG:** Saline control

## Key facts

- **NCT ID:** NCT06448039
- **Lead sponsor:** D. Bradley Welling, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2024-06-15
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** Study drug is no longer available from Nobelpharma
- **Last updated:** 2025-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06448039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06448039, "In-office Repair of Chronic Tympanic Membrane Perforations". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT06448039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*